Showing results (151-160 of 324) with videos related to
Sort By:
Pageof 33
Medical Oncology (Northwood, London, England)|January 9, 2009
Correlation of F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value and EGFR mutations in advanced lung adenocarcinomaChun-Ta Huang, Rouh-Fang Yen, Mei-Fang Cheng, et al.Clinical Lung Cancer|August 5, 2019
Clinical Outcomes of Up-front Surgery Versus Surgery After Induction Chemotherapy for Thymoma and Thymic Carcinoma: A Retrospective StudyWei-Li Ma, Chia-Chi Lin, Feng-Ming Hsu, et al.Clinical and Translational Radiation Oncology|April 14, 2020
Clinical outcomes and toxicity predictors of thoracic re-irradiation for locoregionally recurrent lung cancerWen-Chi Yang, Feng-Ming Hsu, Yu-Hsuan Chen, et al.The Oncologist|May 26, 2019
Cranial Irradiation for Patients with Epidermal Growth Factor Receptor (EGFR) Mutant Lung Cancer Who Have Brain Metastases in the Era of a New Generation of EGFR InhibitorsJih-Hsiang Lee, Hsuan-Yu Chen, Feng-Ming Hsu, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 15, 2014
Biomarker analyses from a randomized, placebo-controlled, phase IIIb trial comparing bevacizumab with or without erlotinib as maintenance therapy for the treatment of advanced non-small-cell lung cancer (ATLAS)Fairooz Kabbinavar, Louis Fehrenbacher, John Hainsworth, et al.Plos One|November 19, 2013
Radiofrequency ablation is superior to ethanol injection in early-stage hepatocellular carcinoma irrespective of tumor sizeZhong-Zhe Lin, Wen-Yi Shau, Chiun Hsu, et al.Oncotargets and Therapy|August 29, 2022
Sequential Afatinib and Osimertinib in Asian Patients with EGFR Mutation-Positive Non-Small Cell Lung Cancer and Acquired T790M: Combined Analysis of Two Global Non-Interventional StudiesSatoru Miura, Hyun Ae Jung, Shin Yup Lee, et al.European Journal of Cancer (Oxford, England : 1990)|June 24, 2014
First-line pemetrexed plus cisplatin followed by gefitinib maintenance therapy versus gefitinib monotherapy in East Asian patients with locally advanced or metastatic non-squamous non-small cell lung cancer: a randomised, phase 3 trialJames Chih-Hsin Yang, Jin Hyoung Kang, Tony Mok, et al.The Oncologist|May 17, 2017
Real-World Data on Prognostic Factors for Overall Survival in EGFR Mutation-Positive Advanced Non-Small Cell Lung Cancer Patients Treated with First-Line GefitinibZong-Han Yao, Wei-Yu Liao, Chao-Chi Ho, et al.Oncotarget|August 28, 2015
Rhodomycin A, a novel Src-targeted compound, can suppress lung cancer cell progression via modulating Src-related pathwaysYi-Hua Lai, Min-Hsuan Chen, Sih-Yin Lin, et al.Pageof 33